わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/08/16 | 日証協 | 411,525株 | -1.58% | 7,344株 | -42.17% | 525,553株 | -1.79% | 15,500株 | -54.28% |
2024/08/09 | 日証協 | 418,125株 | -5.87% | 12,700株 | -48.72% | 535,153株 | -2.08% | 33,900株 | +143.88% |
2024/08/02 | 日証協 | 444,207株 | -13.38% | 24,764株 | -48.41% | 546,505株 | -6.23% | 13,900株 | -58.51% |
2024/07/26 | 日証協 | 512,807株 | -1.4% | 48,000株 | +196.52% | 582,805株 | -0.29% | 33,500株 | +55.09% |
2024/07/19 | 日証協 | 520,107株 | -5.37% | 16,188株 | -88.45% | 584,505株 | -19.6% | 21,600株 | -79.45% |
2024/07/12 | 日証協 | 549,607株 | +2.14% | 140,144株 | +375.26% | 727,005株 | -11.38% | 105,100株 | -62.38% |
2024/07/05 | 日証協 | 538,107株 | +2.22% | 29,488株 | +92.25% | 820,405株 | +42.93% | 279,400株 | +324.99% |
2024/06/28 | 日証協 | 526,407株 | -0.38% | 15,338株 | -84.7% | 574,005株 | -0.34% | 65,742株 | +98.02% |
2024/06/21 | 日証協 | 528,413株 | +20% | 100,227株 | +364.01% | 575,963株 | -3.66% | 33,200株 | +40.68% |
2024/06/14 | 日証協 | 440,330株 | -30.56% | 21,600株 | +33.43% | 597,863株 | -24.6% | 23,600株 | +68.57% |
2024/06/07 | 日証協 | 634,130株 | +0.3% | 16,188株 | +118.76% | 792,963株 | -0.11% | 14,000株 | +1172.73% |
2024/05/31 | 日証協 | 632,230株 | -8.18% | 7,400株 | -75.25% | 793,863株 | -7.8% | 1,100株 | 0% |
2024/05/24 | 日証協 | 688,530株 | -10.11% | 29,900株 | -64.74% | 861,063株 | -5.01% | 1,100株 | -98.76% |
2024/05/17 | 日証協 | 765,984株 | +6.91% | 84,789株 | +6.11% | 906,511株 | +6.38% | 88,615株 | +60.23% |
2024/05/10 | 日証協 | 716,484株 | -0.67% | 79,906株 | +109.55% | 852,108株 | -0.44% | 55,306株 | -72.46% |
2024/05/02 | 日証協 | 721,284株 | -6.08% | 38,133株 | -80.15% | 855,909株 | +0.42% | 200,807株 | +97.05% |
2024/04/26 | 日証協 | 767,984株 | +2.91% | 192,082株 | +35.34% | 852,308株 | +5.92% | 101,906株 | +10.27% |
2024/04/19 | 日証協 | 746,284株 | -2.15% | 141,927株 | +94.27% | 804,708株 | -0.25% | 92,412株 | -57.22% |
2024/04/12 | 日証協 | 762,684株 | +2.31% | 73,056株 | -33.54% | 806,708株 | +4.47% | 216,006株 | +157.73% |
※株式分割は考慮していませんのでご注意ください。
Page Top